Napro is a proud sponsor of WCDGT Cannabis Business Expo where Dr. Mark Lewis will present on #cannabis technology #cannabiscommunity #CBD #cannaculture #legal manetch.com/events/cannabi…

A substance was found in #cannabis that could boost pancreatic #cancer treatments. Thanks The Guardian for sharing! #CBD #cannabiscommunity #naproresearch bit.ly/2vgGchy

Dr. Mark Lewis will be #speaking at this year's DEF CON in Las Vegas, Nevada. To learn more about the event and attend: defcon.org #DEFCON #DEFCON26 #naproresearch #CBD #CannabisCommunity

Dr. Mark Lewis presents at #defcon2018 today ໊ PT on #Hacking #phenotypal #pathways in #Cannabis bit.ly/2OY1Hg9 #cannabisculture #CannabisCommunity

Napro’s Dr. Mark Lewis is honored to have been selected as Chairman of #Cannabis Business Europe 2018 in Frankfurt & to have spoken yesterday on paradigm shifts in #cannabistechnology. #wcdgt #IndustrialHemp #pharma #healthcare #growers #cultivators. bit.ly/2LwlJeA

As #Cannabis Business Europe 2018 comes to a close, NaPro’s Dr. Lewis thanks the many global cannabis industry leaders that shared their insights on trade #partnerships , best practices from production to distribution and #sustainable #growing methods #wcdgt #cannabisindustry

Dr. Mark Lewis is honored to be a keynote speaker at The #Natural #Medicine Congress 2018 where the theme will be New #Frontiers in Natural #Medicine #naturalmedicinecongress #conferences #Medicinalplants naturalproducts.conferenceseries.com

Dr. Mark Lewis is honored to present on #Functional #Cannabis: #Pharmacological #Foundations of #Cannabis #Chemovars Cannabis & Hemp Science Seminar Series Oakland.PerkinElmer #MedicalCannabis #science #cannabisculture

Dr. Mark Lewis is looking forward to his presentation, Chemical Characterization of #Edible #Cannabis at the 5th Flavors, Fragrances and Perception Symposium at Rutgers University on November 30, 2018 cpe.rutgers.edu/CSSI/

What is CBD? And why is the cannabis-derived ingredient on the rise for wellness products? - goo.gl/alerts/VGeRq #GoogleAlerts

Dr. Mark Lewis is looking forward to #CannMed2018 UCLA where he will be joined by panelists Seth Crawford, Ph.D., Jonathan Vaught, Ph.D. and Allison Justice, Ph.D. to discuss #innovations in #cultivation bit.ly/2R1Zpwz #science #cannabis

Dr. Mark Lewis of Napro Research, looks forward to participating on the Innovations in Cultivation Panelist moderated by Canopy Growth’s @KatyaBoudko this wk CannMed UCLA. #CannMed2018 gathers the greatest minds in medical #cannabis, bit.ly/2R1Zpwz

Going to Las Vegas for MJBizCon? Only a few slots remain for meetings, so if you believe we should meet to discuss how our work can help you stand out from the crowd, please drop us a line at [email protected] and put MJBizCon in the subject line #MJBizCon #Cannabis

Napro Research President Dr. Lewis joined a stellar cast of industry, government and academic thought-leaders, as well as developers and manufacturers, as a featured speaker today at the Flavors, Fragrances and Perception Symposium at Rutgers University: cpe.rutgers.edu/CSSI/

Dr. Mark Lewis is traveling to Boston, MA to present at the International Cannabinoid Derived Pharmaceuticals Summit being held 12/11-12/18. international-cdp.com #ICDPSummit2018

Dr. Lewis discussed how plant breeding innovations impact patient’s experiences and the opportunities targeted breeding provides to the biotech and pharma sectors. Innovation panel is next!!!! international-cdp.com #ICDPSummit2018

Looking forward to Emerald Cup 2018. Words cannot express our excitement to see the world’s preeminent genetics all in one location. Presentations by Dr. Russo and Dr. Lewis will bring science and research to the event as well. Gotta love California. The Emerald Cup

A huge shout out to MolecularFarms for sweeping the CBD flowers category at the 2018 Emerald Cup. Molecular also landed fifth overall for SFV Cookies in the licensed sun grown category. The Emerald Cup

The European Food Safety Authority’s (EFSA) classification of CBD as “Novel Food” surprised many. But, the move aligns with the FDA’s exclusion of CBD from the FD&C Act’s dietary supplement definition, making EFSA’s move more anticipated to keen observers, and less unexpected.